![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 44, 34534-34540, November 3, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Medicine and Canadian Institutes for Health Research Group on Molecular and Cell Biology of Lipids, University of Alberta, Edmonton, Alberta T6G 2S2, Canada
Received for publication, April 5, 2000, and in revised form, August 9, 2000
| |
ABSTRACT |
|---|
|
|
|---|
We report the subcellular localization of enzymes
involved in phosphatidylserine biosynthesis in mammalian cells. Several lines of evidence suggest that phosphatidylserine synthase-1 (PSS1) is
highly enriched in mitochondria-associated membranes (MAM) and is
largely excluded from the bulk of the endoplasmic reticulum (ER).
Taking advantage of the substrate specificity of PSS1, we showed that
(i) MAM contain choline exchange activity, whereas this activity is
very low in the bulk of the ER, (ii) serine exchange activity is
inhibited by choline to a much greater extent in MAM than in ER, and
(iii) MAM use phosphatidylcholine and phosphatidylethanolamine as
substrates for phosphatidylserine biosynthesis, whereas the ER utilizes
only phosphatidylethanolamine. According to immunoblotting of proteins
from both CHO-K1 cells and murine liver, PSS1 is localized to MAM, and
in hepatoma cells stably expressing PSS1 this protein is highly
enriched in MAM. Since the ER contains serine and ethanolamine exchange
activities, we had predicted that PSS2 would account for the serine
exchange activity in the ER. Unexpectedly, using immunoblotting
experiments, we found that (i) PSS2 of CHO-K1 cells is present only in
MAM and (ii) PSS2 is restricted to MAM of McArdle cells expressing
recombinant PSS2. These data leave open the question of which enzyme
imparts PSS activity to the ER and suggest that a third isoform of PSS
might be located in the ER.
Many enzymes involved in the final stages of lipid biosynthesis
are integral membrane proteins of the endoplasmic reticulum (ER).1 Examples include
cholinephosphotransferase (1, 2), ethanolaminephosphotransferase (1,
2), phosphatidylethanolamine (PtdEtn) N-methyltransferase (1, 2), diacylglycerol acyltransferase (2), glycerol-3-phosphate acyltransferase, acyl-CoA:cholesterol acyltransferase (2), 3-hydroxy-3-methylglutaryl-CoA reductase (2), and phosphatidylserine (PtdSer) synthase (1, 2). Upon closer examination, however, some of
these enzyme activities are found to be present in additional cellular
locations such as peroxisomes, mitochondria, or mitochondria-associated membranes (MAM) (3). MAM are ER-like membranes that co-isolate with
mitochondria but can be separated from the latter by centrifugation of
crude mitochondria on a Percoll gradient (1). MAM have many, but not
all, properties of the ER (1, 2). In particular, MAM are enriched,
compared with the bulk of ER, in several lipid biosynthetic enzyme
activities, such as acyl-CoA:cholesterol acyltransferase (2),
diacylglycerol acyltransferase (2), some enzymes involved in
biosynthesis of glycosylphosphatidylinositol anchors of proteins (4),
and phosphatidylserine synthase (PSS). The specific activity of PSS is
typically 2-4-fold higher in MAM than in ER (1, 2). A unique protein
marker for MAM is PtdEtn N-methyltransferase-2 (5), an
isoform of the enzyme that converts PtdEtn to phosphatidylcholine (PtdCho) in liver (6). Although ER and MAM contain similar specific
activities for PtdEtn methylation, an antibody generated against PtdEtn
N-methyltransferase-2 recognizes a protein in MAM that is
not detectable in the ER (5). These data indicate that two isoforms of
PtdEtn N-methyltransferase exist; one is specifically located in MAM and excluded from the ER, whereas the other is presumably responsible for the phospholipid methylation activity in the
ER. The function of MAM has not been firmly established, but an
attractive hypothesis is that MAM are involved in the import of PtdSer
into mitochondria via a membrane collision-based mechanism (1, 7).
Indeed, essentially all mitochondrial PtdEtn is produced from
decarboxylation of imported PtdSer (7). Moreover, MAM appear to be
associated with contact sites between mitochondrial inner and outer
membranes (8, 9).
Two PtdSer synthases with distinct substrate specificities have been
identified in mammalian cells. Each catalyzes a base exchange reaction
between serine and preexisting phospholipids. The existence of two
isoforms of PSS was confirmed by isolation and sequencing of two
distinct PSS cDNAs encoding PSS1 and PSS2 that share limited (32%)
sequence identity (10). PSS1 and PSS2 both catalyze serine exchange
activity, whereas only PSS1, and not PSS2, catalyzes choline exchange
(11). In CHO-K1 cells expressing either only PSS1 or only PSS2, PSS1
uses almost exclusively PtdCho as the donor of the phosphatidyl group,
whereas PSS2 uses only PtdEtn (12). The reason why PSS1 can use both
PtdEtn and PtdCho in in vitro enzymatic assays but only
PtdCho in intact cells is not clear.
We now report the subcellular localization of the two PSS isoforms,
PSS1 and PSS2. Previous immunoblotting studies of CHO cells by Saito
et al. (13) detected PSS1 in microsomes as well as in MAM.
However, since microsomes contain MAM, as well as ER and other
organelle membranes, these studies did not exclude the possibility that
the microsomal PSS1 was contributed by MAM alone and was absent from
the ER per se. On the basis of our previous findings that
both MAM and the ER contain PSS activity, we hypothesized that the two
PSS isoforms might be present in spatially distinct locations in the
cell, with one isoform being located in MAM and the other in the ER. We
demonstrate that PSS1 protein is found exclusively in MAM and is not
detectable in the ER. In addition, and contrary to our predictions, we
found that PSS2 is also restricted to MAM. These findings leave open
the question of which PtdSer biosynthetic enzyme is responsible for
serine exchange activity in the ER and suggest that this activity might
be due to a third, presently unknown, PtdSer synthase isoform.
Materials--
CHO-K1 cells and McArdle rat hepatoma 7777 cells
were obtained from the American Type Tissue Culture collection
(Manassas, VA). Fetal bovine serum, horse serum, tissue culture media,
and DNA modifying enzymes were purchased from Life Technologies, Inc. The radiochemicals [3-3H]serine,
[1-3H]ethanolamine, and
[methyl-3H]choline were from Amersham
Pharmacia Biotech. Bovine pancreatic trypsin and soybean trypsin
inhibitor were from Sigma. All other chemicals were from Sigma or Fisher.
Cell Culture--
M.9.1.1 cells (a gift from Dr. D. R. Voelker, National Jewish Research Center, Denver, CO), CHO-K1 cells,
and McArdle 7777 rat hepatoma cells were maintained as described
previously (14).
Antibodies--
Anti-PSS1 and anti-PSS2 antibodies were a
generous gift from Dr. M. Nishijima (National Institute of Health,
Japan). These antibodies were raised in rabbits against synthetic
peptides corresponding to amino acids 1-17 of PSS1 from CHO-K1 cells
and amino acids 458-474 of PSS2 from CHO-K1 cells. The rabbit anti-rat
protein-disulfide isomerase polyclonal antibody was a generous gift
from Dr. M. Michalak (University of Alberta) (15). Anti-myc
antibody was obtained from clone 9E10 hybridoma tissue culture
supernatant and used directly for immunoblotting experiments. The
rabbit anti-rat PtdEtn N-methyltransferase-2 polyclonal
antibody, generated against a C-terminal dodecapeptide of PtdEtn
N-methyltransferase-2, was provided by Dr. D. E. Vance
(University of Alberta) (5). The rabbit anti-rat calnexin polyclonal
antibody was from Stressgen Biotechnologies Corp. (Victoria, Canada).
Preparation of myc Epitope-tagged PSS1 and PSS2
cDNAs--
The myc epitope (EQKLISEEDL) was appended to
the 5'-end of murine PSS1 cDNA (14) and either the 5'- or 3'-end of
murine PSS2 cDNA (16) by the polymerase chain reaction. A
myc-PSS1 mutant was generated by deleting the last two
codons (encoding two lysine residues) of murine PSS1 cDNA. The
cDNA fragments were sequenced by the DNA core facility at the
University of Alberta to confirm the modifications. Each of the
cDNAs encoding myc-PSS1, myc-PSS1 with two
C-terminal lysine residues deleted (myc-PSS1: Double Immunofluorescence--
McArdle cells (80% confluent)
expressing myc-PSS1 and C-myc-PSS2 were diluted
1:10 with fresh medium and plated on coverslips in 100-mm dishes and
then allowed to attach overnight. Cells were fixed with
methanol/acetone (1:1) for 2 min at room temperature and then
preincubated with phosphate-buffered saline containing 3% bovine serum
albumin (w/v) and 0.2% Triton X-100 (v/v) for 1 h. The cells were
incubated with a mixture of anti-myc (1:10 dilution) and
anti-rat calnexin (1:250 dilution) antibodies in phosphate-buffered
saline containing 3% bovine serum albumin (w/v) and 0.02% Triton
X-100 (v/v) for 1 h. After five washes with phosphate-buffered saline containing 0.02% Triton X-100 (v/v), cells were incubated with
secondary antibodies (fluorescein isothiocyanate-conjugated anti-mouse
IgG (1:1000 dilution) and Texas Red-conjugated anti-rabbit IgG (1:100
dilution)) in phosphate-buffered saline containing 0.02% Triton X-100
(v/v) for 30 min. The cells were washed five times with
phosphate-buffered saline containing 0.02% Triton X-100 (v/v) and then
mounted on microscope slides in phenylenediamine mounting medium and
processed for confocal microscopy (Zeiss LSM 510 confocal microscope).
Subcellular Fractionation of Cultured Cells--
Microsomes,
MAM, and mitochondria were isolated from cultured cells by slight
modifications of a method previously described (7). Cells were scraped
into phosphate-buffered saline, pelleted by centrifugation at 500 × g for 5 min, and resuspended in 8 ml of homogenization
buffer (0.25 M sucrose and 10 mM Hepes (pH
7.4)). The cells were gently disrupted by 15 up-and-down strokes in a Potter-Elvehjem motor-driven homogenizer. The homogenate was
centrifuged twice at 600 × g for 5 min to remove
cellular debris and nuclei, and the supernatant was centrifuged at
10,300 × g for 10 min to pellet crude mitochondria.
The resultant supernatant was centrifuged at 100,000 × g for 1 h in a Beckman Ti 70.1 rotor at 4 °C to
pellet microsomes, which were resuspended in homogenization buffer. The mitochondrial pellet was resuspended in 300 µl of isolation medium (250 mM mannitol, 5 mM Hepes (pH 7.4), and 0.5 mM EGTA) and layered on top of 8 ml of Percoll medium (225 mM mannitol, 25 mM Hepes (pH 7.4), 1 mM EGTA, and 30% Percoll (v/v)) in a 10-ml polycarbonate ultracentrifuge tube and then centrifuged for 30 min at 95,000 × g. A dense band containing purified mitochondria was
recovered from approximately 3/4 down the tube. The
mitochondrial band was removed, diluted with isolation medium, and
washed twice by centrifugation at 6300 × g for 10 min
to remove the Percoll, after which the mitochondria were resuspended in
isolation medium. MAM were removed from the Percoll gradient as the
diffuse white band located above the mitochondria. Isolation medium was
added, and the suspension was centrifuged at 6300 × g
for 10 min. The supernatant containing MAM was centrifuged at
100,000 × g for 1 h in a Beckman Ti 70.1 rotor,
and the resulting MAM pellet was resuspended in homogenization buffer.
Subcellular Fractionation of Murine Liver Homogenates--
MAM
and mitochondria were isolated from murine liver as described
previously for rat liver (1). ER fractions enriched in rough ER (ER1)
and smooth ER (ER2) were prepared by the method of Croze and Morre (18)
as modified by Vance and Vance (19). ER1 was isolated from the final
discontinuous sucrose gradient at the interface between sucrose
solutions of 1.5 and 2.0 M. ER2 was isolated from the same
gradient at the interface between sucrose solutions of 1.3 and 1.5 M.
Measurement of PtdSer Synthase Activity--
PtdSer synthase
activity was measured in subcellular fractions of mouse liver as
described previously (19). Cultured cells were scraped from 100-mm
dishes and disrupted by sonication (2 × 10 s) with a probe
sonicator in 10 mM HEPES buffer (pH 7.5) containing 0.25 M sucrose. Lysates were centrifuged for 2 min at 600 × g to pellet cellular debris, and PSS activity was
measured in the supernatant in the presence of 10 mM
calcium using [3-3H]serine (50 µCi/µmol),
[1-3H]ethanolamine (20 µCi/µmol), or
[methyl-3H]choline (10 µCi/µmol) as
substrates (19). In some experiments, as indicated, unlabeled choline
or ethanolamine was added to the reaction mixture to final
concentrations of 0.5, 5, or 50 mM at pH 7.4.
Measurement of PSS Activity Using PtdCho or PtdEtn
Dispersions--
100 µl of 50 mM PtdCho or PtdEtn
dissolved in chloroform were evaporated to dryness under a stream of
N2. The phospholipid residue was resuspended in 0.04%
Triton X-100 to a final concentration of 7 mM, incubated on
ice for 30 min with frequent vortexing, and then sonicated until the
solution cleared. PtdCho or PtdEtn (60 µl of solution) was added to
each PSS assay to a final concentration of 2 mM.
Trypsin Treatment of Membranes--
An aliquot of ER membranes
or MAM was incubated with trypsin (ratio of membrane protein to
trypsin, 2:1 (w/w)) at 37 °C for 15 min. The reaction was terminated
by the addition of 20 µl of trypsin inhibitor (40 mg/ml). Treated
membranes were diluted in isolation medium, and 25 µg of protein from
each fraction was used for the PSS assay.
Immunoblotting--
Proteins were separated by electrophoresis
on 10% (w/v) polyacrylamide gels containing 0.1% SDS and then
transferred to polyvinylidene difluoride membranes in ice-cold 62.5 mM boric acid (pH 8.0) at 60 V for 1 h. Membranes were
blocked by incubation overnight at 4 °C with 5% (w/v) skimmed milk
in T-TBS (20 mM Tris-HCl (pH 7.4) containing 150 mM NaCl and 0.05% Tween 20) and then incubated for 1 h with one antibody (anti-PSS1 (1:2500 dilution), anti-PSS2 (1:2500 dilution), anti-protein-disulfide isomerase (1:1000 dilution), or anti-myc (1:50 dilution) antibody) in T-TBS containing
5% (w/v) milk. The membranes were subsequently washed with T-TBS
containing 5% (w/v) milk and then incubated for 1 h with
peroxidase-conjugated goat anti-rabbit IgG for PSS1, PSS2 or
protein-disulfide isomerase (1:10,000 dilution), or goat anti-mouse IgG
for myc (1:10,000 dilution). Membranes were washed with
T-TBS containing 5% (w/v) milk, and bound antibody was detected by
enhanced chemiluminescence (Amersham Pharmacia Biotech).
Other Methods--
Protein concentrations were determined by the
BCA method (Pierce) using bovine serum albumin as a standard.
PtdSer Synthase Exchange Activities in ER and MAM--
We have
previously shown that serine exchange activity is present in the ER and
is relatively enriched in MAM (1, 2). As a first approach to
determining the subcellular locations of PSS1 and PSS2, we compared the
substrate specificities for base exchange in subcellular fractions by
assessing the ability of unlabeled choline or ethanolamine to inhibit
serine exchange activity. Since PSS1 exchanges all three bases (serine,
choline, and ethanolamine) in in vitro assays, unlabeled
choline and ethanolamine would be expected to compete with radiolabeled
serine in a serine exchange assay (11). In contrast, since PSS2
catalyzes the exchange of serine and ethanolamine, but not choline, one
would expect that ethanolamine, but not choline, would compete with
radiolabeled serine in the in vitro serine exchange assay.
The addition of 5 mM ethanolamine to the serine exchange
assay mixture inhibited the serine exchange activity of the ER and MAM
by 92 and 85%, respectively (Fig. 1).
Although 0.5 and 5 mM choline inhibited the serine exchange
activity in MAM by ~40 and 70%, respectively, the serine exchange
activity in the ER was not inhibited by 0.5 mM choline and
inhibited only slightly, if at all, by 5 mM choline (Fig.
1). Additional data presented below demonstrate that MAM also contain
PSS2; therefore, one would not expect the serine exchange activity of
MAM to be completely inhibited by choline. These observations suggest
that choline exchange activity (i.e. PSS1) is primarily
concentrated in the MAM, since the serine exchange activity was much
more potently inhibited by choline in the MAM than in the ER. When the
choline concentration was increased to 50 mM, inhibition of
the serine exchange activity in the MAM increased to 83%, whereas the
activity in the ER was inhibited by ~40%. We found that 50 mM choline modestly inhibits the serine exchange activity
in M.9.1.1 cells (which lack PSS1), by ~20%. Kuge et al.
(11) reported that in PSA3 cells (in which PSS1 is defective and
choline exchange is <1% of that in parental CHO cells) 5 mM choline inhibited serine exchange activity by ~20%.
The partial inhibition by 50 mM choline of the serine
exchange activity in the ER probably reflects a combination of some
inhibition of PSS2 serine exchange activity by the very high
concentration of choline and the presence of small amounts of PSS1 in
the ER.
Sensitivity of PSS1 and PSS2 Activity to Trypsinization of ER and
MAM--
In order to establish further the biochemical properties,
subcellular locations, and topology of PSS1 and PSS2, ER and MAM were
incubated with trypsin. Our laboratory has previously demonstrated that
trypsin proteolysis of ER membranes results in the loss of only ~60%
of serine exchange activity, whereas the same treatment inactivates
another ER membrane protein, cholinephosphotransferase, by almost 100%
(19). Choline, ethanolamine, and serine exchange activities were
measured in ER and MAM that had been preincubated with or without
trypsin. The data in Fig. 2 demonstrate
that MAM contain choline exchange activity, whereas this activity is
essentially absent from the ER, supporting the idea that PSS1 is
localized to MAM, whereas the ER is almost devoid of PSS1. After
proteolysis, the serine and choline exchange activities of MAM and ER
were decreased by >80% (Fig. 2). In MAM, ~85% of the ethanolamine
exchange activity was inactivated by trypsin treatment. In contrast,
the ethanolamine exchange activity of the ER was reduced by only 35%. As a positive control to confirm that the trypsin was proteolytically active, trypsin treatment under the same conditions reduced the PtdEtn
N-methyltransferase activity by 96% in the ER and by 84% in MAM. The relative resistance of the ethanolamine exchange activity in the ER to proteolysis suggests that the PSS(s) responsible for
ethanolamine exchange in the ER and MAM might be either structurally distinct or have different topological arrangements in the
membrane.
Phospholipid Substrate Preference of PSS1 and PSS2 in ER and
MAM--
In addition to using the free bases for the base exchange
reaction, PSS also uses phospholipids as substrates. PSS1 uses both PtdCho and PtdEtn, whereas PSS2 uses only PtdEtn (20). Serine exchange
activity was measured in the ER and MAM with exogenously added PtdEtn
and PtdCho in the presence of the detergent Triton X-100. Very little
serine exchange activity was detected in membranes assayed in the
absence of exogenously added phospholipid (Fig. 3) because Triton X-100 inhibits the
reaction (19). PtdEtn stimulated the serine exchange activity of both
ER and MAM, but the enzyme-specific activity was 39% less in the ER
than in MAM (Fig. 3). In addition, PtdCho stimulated the serine
exchange activity in MAM (by ~18-fold) to a greater extent than in
the ER (by ~6-fold).
A combination of the results presented in Figs. 1-3 suggests that the
bulk of PSS1, which is responsible for choline exchange activity,
resides in MAM, whereas the ER contains little PSS1. In addition,
ethanolamine exchange activity, which is contributed by both PSS1 and
PSS2 in vitro, is present in both ER and MAM. These
experiments do not, however, permit us to determine whether the
ethanolamine exchange activity in the ER and MAM is contributed by PSS1
or PSS2.
Localization of PSS1 and PSS2 by Immunofluorescence
Microscopy--
The subcellular localization of PSS1 and PSS2 was
further investigated using immunofluorescence confocal microscopy. A
myc epitope tag was appended to the 5'-end of the cDNA
encoding murine PSS1 and to the 3'-end of the cDNA encoding PSS2
(C-myc-PSS2), and the constructs were stably transfected
into McArdle rat hepatoma cells. The localization of these proteins was
compared with that of calnexin, a resident ER membrane chaperone
protein, using double immunofluorescence confocal microscopy with
antibodies directed against the myc epitope and calnexin.
Staining for calnexin showed a punctate pattern of fluorescence
throughout the cytoplasm, consistent with that expected for an ER
protein (Fig. 4, B and
E). No immunoreactivity was observed in cells from which the
primary antibody had been omitted (data not shown). myc-PSS1
(Fig. 4A) and C-myc-PSS2 (Fig. 4D)
showed similar staining patterns that were somewhat more diffuse than
that of calnexin (Fig. 4, B and E). Overall,
however, PSS1 and PSS2 extensively co-localized with each other and
with the ER marker, calnexin (Figs. 4, C and
F).
Immunoloblotting Analysis of Localization of PSS1--
We next
determined by immunoblotting experiments if PSS1 protein was localized
to MAM or was distributed throughout the ER. Proteins of MAM isolated
from CHO-K1 and M.9.1.1 cells (mutant CHO cells defective in PSS1
activity) (20) were immunoblotted with anti-PSS1 antibody. Fig.
5A shows that PSS1 was present
in MAM of wild-type CHO-K1 cells but was not detectable in MAM of M.9.1.1 cells (Fig. 5A). In addition, small amounts of PSS1
were detected in microsomes isolated from CHO-K1 cells but not in
microsomes from M.9.1.1 cells (not shown). These results were as
expected, since PSS1 activity is greatly reduced in M.9.1.1 cells (14, 20) and these cells also lack detectable PSS1 mRNA (16). These observations are consistent with the report of Saito et al.
(13), who showed that PSS1 was present in MAM and, to a lesser extent, in microsomes of CHO-K1 cells.
Microsomes are ER-enriched membranes that in addition to ER contain
other organelle membranes including MAM. Consequently, the possibility
existed that the presence of PSS1 in microsomes was due to MAM rather
than the bulk of the ER. We therefore isolated MAM, mitochondria, and
two membrane fractions highly enriched in ER from murine liver (18):
ER1, which is enriched in rough ER, and ER2, which is enriched in
smooth ER. Immunoblotting with anti-PSS1 antibody showed that PSS1 is
localized to MAM (Fig. 5B); neither ER1 nor ER2 contained
any detectable PSS1 protein (Fig. 5B). Included in Fig.
5B are immunoblots of the same membrane proteins probed with
an antibody directed against rat liver PtdEtn N-methyltransferase-2, a specific marker protein for MAM
(5). Similar to PSS1, and in agreement with previous observations (5), PtdEtn methyltransferase-2 was present in MAM but was absent from ER1
and ER2 (Fig. 5B). To confirm that the ER1 and ER2 fractions were indeed derived from the ER, the membrane proteins were also immunoblotted with an antibody directed against protein-disulfide isomerase, a resident ER protein. Protein-disulfide isomerase immunoreactivity was observed in ER1, ER2, and MAM and was absent from
mitochondria (Fig. 5B), confirming that ER1 and ER2 are
derived from the ER. These immunoblotting data demonstrate that in
murine liver PSS1 resides in MAM but is undetectable in the ER and
suggest that the PSS1 detected in microsomes of CHO-K1 cells was due to MAM being a constituent of the microsomal preparation.
One possible explanation for the apparent absence of PSS1 from the ER
is that proteolytic cleavage of the N terminus of PSS1 occurs,
generating a truncated protein that would not be recognized upon
immunoblotting with the antibody used (the data in Fig. 5 were
generated using an antibody directed against a peptide consisting of
amino acids 1-17 of PSS1 from CHO-K1 cells). Therefore, if the ER had
contained an isoform of PSS1 that lacked this N-terminal epitope, no
immunoreactive protein would have been detected in the ER. However,
this scenario is unlikely because Saito et al. (13)
previously examined the subcellular location of PSS1 in CHO cells using
two different antibodies, one directed against a peptide close to the N
terminus (amino acids 4-18) of PSS1 and the other directed against a
peptide close to the C terminus (amino acids 447-463). Immunoreactive
PSS1 protein with a molecular mass of 42 kDa was detected in membrane
fractions of CHO cells using either antibody, suggesting that neither
the N nor the C terminus of PSS1 in the membranes had been cleaved. In
this study by Saito et al., the immunoreactive protein
exhibited an anomalously low apparent molecular mass of 42 kDa upon
polyacrylamide gel electrophoresis compared with the size predicted
from the cDNA sequence (55.3 kDa). This atypical behavior of PSS1
upon electrophoresis was attributed to the exceptionally high content
of hydrophobic amino acids in PSS1 (13). The PSS1 detected in our
immunoblotting studies, using an antibody directed against the N
terminus of PSS1 (amino acids 1-17), also has an apparent molecular
mass of 42 kDa. In addition, data presented in Fig.
6, in which myc-tagged PSS1
was expressed in McArdle hepatoma cells and detected by immunoblotting with anti-myc antibody, also support the conclusion that
PSS1 is highly enriched in the MAM but undetectable in the ER.
Moreover, the observation that the ER contains little choline exchange
activity (Fig. 2) supports the conclusion that PSS1 is highly enriched in MAM and is largely absent from the ER. However, the possibility that
an N-terminally truncated isoform of PSS1 is present in the ER, which
would not have been detected by our immunoblotting experiments, cannot
be discounted.
The C-terminal KK Motif of PSS1 Is Not Required for Targeting to
MAM--
PSS1 contains two lysine residues at the carboxyl terminus of
PSS1 (residues 472 and 473, i.e. -KK-COOH) (14, 21). This motif is similar to that of reported ER-targeting consensus sequences (-KXKXX-COOH or
-XXKKXX-COOH) (22-24). Since the results
presented in Fig. 5 show that PSS1 is highly enriched in MAM, we
hypothesized that the KK motif might be required for targeting PSS1 to
MAM. The MAM marker protein, PtdEtn N-methyltransferase,
similarly contains a highly positively charged C-terminal sequence
(-RRKATRLHKRS-COOH) (5). We therefore generated a cDNA encoding a
mutant form of murine PSS1 in which the two lysine residues at
positions 472 and 473 were deleted (this mutant is designated as
PSS1: PSS2 Is Also Localized Specifically to MAM--
Since the
preceding data demonstrated that PSS1 was undetectable in the ER but
was highly enriched in the MAM, we hypothesized that the serine and
ethanolamine exchange activities in the ER would be imparted by PSS2.
Support for the idea that the ER contains PSS2 comes from the
observations that (i) the serine exchange activity in the ER is
robustly stimulated by PtdEtn (Fig. 3), (ii) the ER contains
ethanolamine exchange activity (Fig. 2), and (iii) serine exchange
activity of the ER is inhibited by ethanolamine (Fig. 1). Microsomes,
MAM, and mitochondria were isolated from CHO-K1 cells, and the proteins
were immunoblotted with an antibody directed against a peptide
corresponding to the C-terminal sequence of PSS2 from CHO cells. Fig.
7 shows the unexpected result that although PSS2 was abundant in MAM, little immunoreactive PSS2 (Mr ~52 kDa) was detectable in microsomes from
CHO cells.
Unfortunately, the anti-PSS2 antibody, which is directed against a
peptide sequence of PSS2 from CHO cells, does not cross-react with
murine liver PSS2, and all of our attempts to generate an anti-murine
PSS2 antibody have been unsuccessful. Therefore, as an alternative
approach to confirm that PSS2 is present primarily in MAM, we generated
McArdle cells stably expressing murine PSS2 containing a C-terminal
myc tag. In these cells, the serine exchange activity
(specific activity 5.1 nmol/h/mg of protein) was ~7-fold higher than
in control cells transfected with empty vector (specific activity 0.69 nmol/h/mg of protein). Immunoblotting of cellular lysates with
anti-myc antibody confirmed that C-myc-PSS2
protein was expressed in the McArdle cells (Fig.
8A), as indicated by the
presence of an ~52-kDa immunoreactive protein that was absent from
cells transfected with empty vector alone. Subcellular fractions (microsomes, MAM, and mitochondria) were prepared from
C-myc-PSS2-expressing cells and control cells, and
proteins were immunoblotted with anti-myc antibody.
Consistent with the results shown in Fig. 7 for CHO cells,
C-myc-PSS2 was abundant in MAM but was undetectable in
microsomes and mitochondria (Fig. 8B).
We considered the possibility that the apparent absence of PSS2 from
the ER according to immunoblotting (Fig. 8) was the result of
proteolytic cleavage of the myc epitope from the C terminus of the protein in the ER. This possibility was investigated by expression of a cDNA encoding PSS2 with a myc tag
appended to the N terminus in McArdle cells. N-myc-PSS2
protein was also detected in the MAM but not in microsomes by
immunoblotting using an anti-myc antibody (data not shown).
Since N-myc-PSS2 and C-myc-PSS2 were similarly
localized to the MAM, the presence of the myc tag clearly did not affect their subcellular targeting. The lack of immunoreactive PSS2 in the ER was probably not due to proteolytic cleavage of either
the N or C terminus to generate a truncated PSS2. The data do not,
however, eliminate the possibility that a truncated isoform of PSS2,
from which both the N and C termini have been proteolytically cleaved,
is present in the ER, but to our knowledge there are no known examples
of such proteins in the ER. We therefore conclude that both PSS1 and
PSS2 are highly enriched in the MAM but are largely excluded from the
ER.
Conclusion--
The studies presented herein show that full-length
PSS1 and PSS2 are localized almost exclusively to MAM and are largely
excluded from the bulk of the ER. However, the possibility that
truncated isoforms of these proteins are present in the ER cannot be
completely eliminated. The reason why both PSS1 and PSS2 are so highly
enriched in MAM is not clear. Our previous studies have demonstrated
that nearly all mitochondrial PtdEtn is derived from imported PtdSer (7). Therefore, one possible explanation for the localization of the
two PtdSer synthases in MAM is that a robust synthesis of PtdSer at
this site, in close proximity to mitochondrial outer membranes, would
provide an efficient mechanism for the import of newly synthesized
PtdSer into mitochondria for decarboxylation to PtdEtn. The findings of
the present study, however, leave open the question of which protein is
responsible for the serine and ethanolamine exchange activities in the
ER. Saito et al. (12) have used a CHO-K1 cell line, PSA-3,
which is defective in PSS1, to generate a mutant cell line, PSB-2. The
PSB-2 cells are defective in both PSS1 and PSS2 and contain essentially
no choline exchange activity. The ethanolamine and serine exchange
activities of PSB-2 cells are reduced to 4.8 and 11.5%, respectively,
of those in wild-type CHO-K1 cells. It is possible that the residual
base exchange activity detected in PSB-2 cells is contributed by a putative "ER isoform" of PSS, which, as indicated by our trypsin proteolysis experiments, might have a different structure and/or a
different topological arrangement in the ER membranes compared with
PSS1 and PSS2 in the MAM.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
cKK), and
myc-PSS2 with the myc tag appended to either the
N terminus (N-myc-PSS2) or the C terminus
(C-myc-PSS2) was inserted into the eukaryotic expression
vector pcDNA 3.1 (Invitrogen). McArdle rat hepatoma cell lines were
transfected with 10 µg of the cDNAs using the calcium phosphate
precipitation method (17). Stable transfectants were selected by
culturing the cells in medium containing 600 µg/ml G418. Individual
colonies were isolated. When cell lines had been established, the
concentration of G418 was reduced to 200 µg/ml. Control cells for
experiments with McArdle cells were transfected with the expression
vector lacking a cDNA insert.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (33K):
[in a new window]
Fig. 1.
Competition of [3H]serine
exchange activity in murine liver subcellular fractions by choline and
ethanolamine. Serine exchange activity was measured in the
presence or absence of unlabeled choline or ethanolamine, as indicated,
at final concentrations of 0.5 or 5 mM. Data are
averages ± S.D. of triplicate analyses from two independent
experiments. Some error bars are too small to be visible.

View larger version (21K):
[in a new window]
Fig. 2.
Sensitivity of serine, ethanolamine, and
choline exchange activity to trypsin treatment of ER and MAM. PSS
activity was measured in murine liver ER and MAM fractions that had
been incubated in the absence (closed bars) or
presence (open bars) of trypsin. The substrates
used were [3H]serine, [3H]ethanolamine, and
[3H]choline. Data are averages ± S.D. of triplicate
analyses from three independent experiments.

View larger version (38K):
[in a new window]
Fig. 3.
PSS activity in murine liver MAM and ER in
the presence of exogenously added phospholipid substrates. Serine
exchange activity was measured in mouse liver subcellular fractions in
the presence or absence of exogenous PtdCho or PtdEtn (final
concentration 2 mM in 0.04% Triton X-100). No
additions, 0.04% Triton X-100. Data are averages ± S.D. of triplicate analyses from two independent experiments.

View larger version (42K):
[in a new window]
Fig. 4.
Fluorescence immunolocalization of
myc-PSS1 and myc-PSS2 in hepatoma
cells. McArdle rat hepatoma cells expressing myc-PSS1
or -PSS2 were fixed and permeabilized and then incubated with a mixture
of mouse anti-myc and rabbit anti-calnexin antibodies.
Fluorescein isothiocyanate-conjugated anti-mouse IgG and Texas
Red-conjugated anti-rabbit IgG, respectively, were used to detect
myc-PSS1 (A and C) and
myc-PSS2 (D and F) and calnexin
(B, C, E, and F).
Co-localization of calnexin with PSS1 or PSS2 is indicated by
yellow (C and F).

View larger version (39K):
[in a new window]
Fig. 5.
Subcellular distribution of PSS1 in CHO cells
and murine liver. Subcellular membrane fractions were isolated
from CHO-K1 and M.9.1.1 cells (A) and murine liver
(B). Proteins (50 µg) were separated by electrophoresis on
10% polyacrylamide gels containing 0.1% SDS and then transferred to
polyvinylidene difluoride membranes and probed with affinity-purified
antibody directed against PSS1. The band corresponding to PSS1 is
indicated by the arrow at 42 kDa. A, MAM isolated
from CHO-K1 and M.9.1.1 cells. B, ER1, membranes
enriched in rough ER; ER2, membranes enriched in smooth ER;
mito, mitochondria. After the membrane had been probed with
anti-PSS1 antibody, the membrane was reprobed with anti-rat PtdEtn
N-methyltransferase-2 (PEMT2) antibody and
subsequently with anti-rat protein-disulfide isomerase (PDI)
antibody.

View larger version (31K):
[in a new window]
Fig. 6.
Expression of murine cDNAs encoding
myc-PSS1 in McArdle hepatoma cells. The
myc epitope was added to the N terminus of murine cDNAs
encoding PSS1 and a mutant form of murine PSS1 from which the
C-terminal two lysine residues had been deleted (designated
PSS1:
cKK). A, serine exchange activity in cellular
lysates from McArdle cells transfected with empty expression vector
(control), myc-PSS1 (PSS1), and
myc-PSS1:
cKK (PSS1:
cKK). Data
are averages ± S.D. of triplicate analyses from three independent
experiments. B, 50 µg of protein from cellular lysates was
separated by electrophoresis on a 10% polyacrylamide gel containing
0.1% SDS. Proteins were transferred to polyvinylidene difluoride
membranes and incubated with anti-myc antibody. Recombinant
PSS1 proteins are indicated by the arrow at 42 kDa on the
right. C, microsomes (Micr.), MAM, and
mitochondria (Mito.) were isolated from the same cells, and
proteins (50 µg) were separated by polyacrylamide gel electrophoresis
and then immunoblotted with anti-myc antibody. McArdle cells
were transfected with empty expression vector (lanes
1), myc-PSS1 (lanes 2), or
myc-PSS1:
cKK (lanes 3).
cKK). In addition, a myc epitope tag was appended to
the N terminus of PSS1 and PSS1:
cKK, and the cDNA constructs
were stably expressed in McArdle rat hepatoma cells. To confirm that
these modifications did not affect the activity of the expressed PSS1
protein, serine exchange activity was measured in cellular lysates.
Fig. 6A shows that the expressed myc-PSS1 and the
deletion mutant, myc-PSS1:
cKK, possessed approximately
equal serine exchange activities, at levels ~5-fold higher than in
cells transfected with empty expression vector. Immunoblotting of
cellular lysates with anti-myc antibody confirmed that the
transfected cells also expressed approximately equal amounts of the two
recombinant myc-tagged proteins (apparent molecular mass 42 kDa) (Fig. 6B). To determine whether or not the C-terminal
lysine residues at positions 472 and 473 of PSS1 were required for the
targeting of PSS1 to MAM, subcellular fractions (MAM, microsomes, and
mitochondria) were isolated from the transfected cells, and
immunoblotting experiments were performed using anti-myc antibody. In cells expressing either myc-PSS1 or
myc-PSS1:
cKK, the majority of recombinant PSS1 protein
was found in MAM. Both proteins were also present at lower levels in
microsomes but were absent from mitochondria (Fig. 6C).
Therefore, deletion of the lysines at positions 472 and 473 did not
hinder the targeting of PSS1 to MAM. Moreover, the
myc-tagged PSS1 was predominantly located in the MAM.
![]()
View larger version (21K):
[in a new window]
Fig. 7.
PSS2 is localized to MAM in CHO-K1
cells. Microsomes (Micr.), MAM, and mitochondria
(Mito.) were isolated from CHO-K1 cells. Proteins (50 µg)
were separated by electrophoresis on a 10% polyacrylamide gel
containing 0.1% SDS and then transferred to polyvinylidene difluoride
membranes and incubated with affinity-purified antibody directed
against a synthetic peptide corresponding to a sequence of PSS2 from
CHO-K1 cells. PSS2 is indicated by the arrow at ~52
kDa.

View larger version (30K):
[in a new window]
Fig. 8.
myc-PSS2 is localized to MAM in
McArdle hepatoma cells. The myc epitope was appended to
the C terminus of murine PSS2 cDNA. A, proteins of cell
lysates (50 µg of protein) from McArdle cells transfected with empty
expression vector (Control) or myc-PSS2 were
separated by polyacrylamide gel electrophoresis and then immunoblotted
using anti-myc antibody. B, microsomes
(Micr.), MAM, and mitochondria (Mito.) were
isolated from McArdle cells expressing myc-PSS2. Proteins
(50 µg) from each fraction were separated by electrophoresis on a
10% polyacrylamide gel containing 0.1% SDS, transferred to a
polyvinylidene difluoride membrane, and then incubated with
anti-myc antibody. The PSS2 protein is indicated by the
arrow at ~52 kDa.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Russ Watts and Igor Cvetkovic for excellent technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by an operating grant (to J. E. V.) and a studentship (to S. J. S.) from the Medical Research Council of Canada.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: 332 Heritage Medical
Research Center, University of Alberta, Edmonton, Alberta T6G 2S2,
Canada. Tel.: 780-492-7250; Fax: 780-492-3383; E-mail: jean.vance@ualberta.ca.
Published, JBC Papers in Press, August 10, 2000, DOI 10.1074/jbc.M002865200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ER, endoplasmic reticulum; CHO, Chinese hamster ovary; MAM, mitochondria-associated membranes; PtdCho, phosphatidylcholine; PtdEtn, phosphatidylethanolamine; PtdSer, phosphatidylserine; PSS, phosphatidylserine synthase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Vance, J. E. (1990) J. Biol. Chem. 265, 7248-7256 |
| 2. | Rusiñol, A. E., Cui, Z., Chen, M. H., and Vance, J. E. (1994) J. Biol. Chem. 269, 27494-27502 |
| 3. | Vance, J. E. (1998) Trends Biochem. Sci. 23, 423-428 |
| 4. | Vidugiriene, J., Sharma, D. K., Smith, T. K., Baumann, N. A., and Menon, A. K. (1999) J. Biol. Chem. 274, 15203-15212 |
| 5. | Cui, Z., Vance, J. E., Chen, M. H., Voelker, D. R., and Vance, D. E. (1993) J. Biol. Chem. 268, 16655-16663 |
| 6. | Vance, D. E., Walkey, C. J., and Cui, Z. (1997) Biochim. Biophys. Acta 1348, 142-150 |
| 7. | Shiao, Y.-J., Lupo, G., and Vance, J. E. (1995) J. Biol. Chem. 270, 11190-11198 |
| 8. | Ardail, D., Lerme, F., and Louisot, P. (1991) J. Biol. Chem. 266, 7978-7981 |
| 9. | Ardail, D., Gasnier, F., Lerme, F., Simonot, C., Louisot, P., and Gateau-Roesch, O. (1993) J. Biol. Chem. 268, 25985-25992 |
| 10. | Kuge, O., Saito, K., and Nishijima, M. (1997) J. Biol. Chem. 272, 19133-19139 |
| 11. | Kuge, O., Nishijima, M., and Akamatsu, Y. (1986) J. Biol. Chem. 261, 5795-5798 |
| 12. | Saito, K., Nishijima, M., and Kuge, O. (1998) J. Biol. Chem. 273, 17199-17205 |
| 13. | Saito, K., Kuge, O., Akamatsu, Y., and Nishijima, M. (1997) FEBS Letts. 395, 262-266 |
| 14. | Stone, S. J., Cui, Z., and Vance, J. E. (1998) J. Biol. Chem. 273, 7293-7302 |
| 15. | Baksh, S., Burns, K., Andrin, C., and Michalak, M. (1995) J. Biol. Chem. 270, 31338-31344 |
| 16. | Stone, S. J., and Vance, J. E. (1999) Biochem. J. 342, 57-64 |
| 17. | Chen, C., and Okayama, H. (1987) Mol. Biol. Cell 7, 2745-2752 |
| 18. | Croze, E. M., and Morre, D. J. (1984) J. Cell. Physiol. 119, 46-57 |
| 19. | Vance, J. E., and Vance, D. E. (1988) J. Biol. Chem. 263, 5898-5908 |
| 20. | Voelker, D. R., and Frazier, J. L. (1986) J. Biol. Chem. 261, 1002-1008 |
| 21. | Kuge, O., Nishijima, M., and Akamatsu, Y. (1991) J. Biol. Chem. 266, 24184-24189 |
| 22. | Schutze, M.-P., Peterson, P. A., and Jackson, M. R. (1994) EMBO J. 13, 1696-1705 |
| 23. | Nilsson, T., Jackson, M., and Peterson, P. A. (1989) Cell 58, 707-718 |
| 24. | Jackson, M. R., and Peterson, P. A. (1990) EMBO J. 9, 3153-3162 |
This article has been cited by other articles:
![]() |
J. E. Vance Thematic Review Series: Glycerolipids. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids J. Lipid Res., July 1, 2008; 49(7): 1377 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Arikketh, R. Nelson, and J. E. Vance Defining the Importance of Phosphatidylserine Synthase-1 (PSS1): Unexpected Viability of PSS1-Deficient Mice J. Biol. Chem., May 9, 2008; 283(19): 12888 - 12897. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bozidis, C. D. Williamson, and A. M. Colberg-Poley Mitochondrial and Secretory Human Cytomegalovirus UL37 Proteins Traffic into Mitochondrion-Associated Membranes of Human Cells J. Virol., March 15, 2008; 82(6): 2715 - 2726. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Griffin, D. Clarke, C. McCormick, D. Rowlands, and M. Harris Signal Peptide Cleavage and Internal Targeting Signals Direct the Hepatitis C Virus p7 Protein to Distinct Intracellular Membranes J. Virol., December 15, 2005; 79(24): 15525 - 15536. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kvam, K. Gable, T. M. Dunn, and D. S. Goldfarb Targeting of Tsc13p to Nucleus-Vacuole Junctions: A Role for Very-Long-Chain Fatty Acids in the Biogenesis of Microautophagic Vesicles Mol. Biol. Cell, September 1, 2005; 16(9): 3987 - 3998. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Shields, S. Lingrell, L. B. Agellon, J. T. Brosnan, and D. E. Vance Localization-independent Regulation of Homocysteine Secretion by Phosphatidylethanolamine N-Methyltransferase J. Biol. Chem., July 22, 2005; 280(29): 27339 - 27344. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Vo, H. J. Greenberg, and B. O. Palsson Reconstruction and Functional Characterization of the Human Mitochondrial Metabolic Network Based on Proteomic and Biochemical Data J. Biol. Chem., September 17, 2004; 279(38): 39532 - 39540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pottekat and A. K. Menon Subcellular Localization and Targeting of N-Acetylglucosaminyl Phosphatidylinositol De-N-acetylase, the Second Enzyme in the Glycosylphosphatidylinositol Biosynthetic Pathway J. Biol. Chem., April 16, 2004; 279(16): 15743 - 15751. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Pei, N. A. Oey, M. M. Zuidervaart, Z. Jia, Y. Li, S. J. Steinberg, K. D. Smith, and P. A. Watkins The Acyl-CoA Synthetase "Bubblegum" (Lipidosin): FURTHER CHARACTERIZATION AND ROLE IN NEURONAL FATTY ACID {beta}-OXIDATION J. Biol. Chem., November 21, 2003; 278(47): 47070 - 47078. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kuge and M. Nishijima Biosynthetic Regulation and Intracellular Transport of Phosphatidylserine in Mammalian Cells J. Biochem., April 1, 2003; 133(4): 397 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Bergo, B. J. Gavino, R. Steenbergen, B. Sturbois, A. F. Parlow, D. A. Sanan, W. C. Skarnes, J. E. Vance, and S. G. Young Defining the Importance of Phosphatidylserine Synthase 2 in Mice J. Biol. Chem., November 27, 2002; 277(49): 47701 - 47708. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tauchi-Sato, S. Ozeki, T. Houjou, R. Taguchi, and T. Fujimoto The Surface of Lipid Droplets Is a Phospholipid Monolayer with a Unique Fatty Acid Composition J. Biol. Chem., November 8, 2002; 277(46): 44507 - 44512. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sturbois-Balcerzak, S. J. Stone, A. Sreenivas, and J. E. Vance Structure and Expression of the Murine Phosphatidylserine Synthase-1 Gene J. Biol. Chem., March 9, 2001; 276(11): 8205 - 8212. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kuge, Y. Yamakawa, and M. Nishijima Enhancement of Transport-dependent Decarboxylation of Phosphatidylserine by S100B Protein in Permeabilized Chinese Hamster Ovary Cells J. Biol. Chem., June 22, 2001; 276(26): 23700 - 23706. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Lewin, J.-H. Kim, D. A. Granger, J. E. Vance, and R. A. Coleman Acyl-CoA Synthetase Isoforms 1, 4, and 5 Are Present in Different Subcellular Membranes in Rat Liver and Can Be Inhibited Independently J. Biol. Chem., June 29, 2001; 276(27): 24674 - 24679. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||